Article
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2
25 Aug 2014
Abstract excerpt
BACKGROUND: Although the incidence of glioma is relatively low, it is the most malignant tumor of the central nervous system. The prognosis of high-grade glioma patient is very poor due to the difficulties in complete resection and resistance to radio-/chemotherapy. Therefore, it is worth investigating the molecular mechanisms involved in glioma drug resistance. MicroRNAs have been found to play important roles...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
